APA (7th ed.) Citation

Voors, A. A., Angermann, C. E., Teerlink, J. R., Collins, S. P., Kosiborod, M., Biegus, J., . . . Ponikowski, P. (2022). The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: A multinational randomized trial. Nature medicine, 28(3), . https://doi.org/10.1038/s41591-021-01659-1

Chicago Style (17th ed.) Citation

Voors, Adriaan A., et al. "The SGLT2 Inhibitor Empagliflozin in Patients Hospitalized for Acute Heart Failure: A Multinational Randomized Trial." Nature Medicine 28, no. 3 (2022). https://doi.org/10.1038/s41591-021-01659-1.

MLA (9th ed.) Citation

Voors, Adriaan A., et al. "The SGLT2 Inhibitor Empagliflozin in Patients Hospitalized for Acute Heart Failure: A Multinational Randomized Trial." Nature Medicine, vol. 28, no. 3, 2022, https://doi.org/10.1038/s41591-021-01659-1.